Publications

Unno R, Akutagawa J, Song H, Hui K, Chen YA, Pham JH, Lee J, Yang H, Huang FW, Chi T. A single cell transcriptional profile of benign prostatic hyperplasia. Scientific Reports. 2026. PMID: 41832222

Expert Panel on Gastrointestinal Imaging, Yacoub JH, Yano M, Chang KJ, Bergsland E, Bhosale PR, Cash BD, Chernyak V, Gupta A, Hallet J, Halpern J, Magnetta M, Noronha CF, Refaat T, Korngold EK. ACR Appropriateness Criteria® Staging and Follow-Up of Pancreatic Neuroendocrine Tumors. Journal of the American College of Radiology : JACR. 2026. PMID: 41823937

Keenan BP, Fan Z, Le BK, Harris Q, Chen J, Clark M, Lea A, Zhang L, Cheung A, Lara F, Gordan JD, Bracci P, Behr SC, Fong L, Venook AP, Kim EJ, Kelley RK. Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunction. JHEP reports : innovation in hepatology. 2026. PMID: 41831609

Delaveris CS, Loudermilk RP, Pandey A, Remesh SG, Peters-Clarke TM, Ganjave SD, Dougherty WJN, Delavan HM, Wang C, Ling J, Camara Serrano JA, Salangsang F, Ding CC, Greenland N, Chu CE, Porten S, Steri V, Chou J, Evans MJ, Leung KK, Wells JA. Autophagolysosomal exocytosis inverts Src kinase onto the cell surface in cancer. Science (New York, N.Y.). 2026. PMID: 41818370

Gracilla DE, Menon S, Breese MR, Lin YP, Dela Cruz FS, Feinberg TY, de Stanchina E, Galic AF, Allegakoen H, Perati SR, Everin N, Vizconde T, Wen NJ, Heslin A, Somwar R, Ladanyi M, Horlbeck M, Weissman JS, Sweet-Cordero EA, Bivona TG, Tulpule A. FET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor Therapy. Cancer research. 2026. PMID: 41811428

Artz AS, Logan B, Saber W, Geller N, Bellach A, Kou J, Wood WA, McCarty JM, Knight TG, Runaas L, Johnston L, Walston J, Nakamura R, Mishra A, Uberti J, Dahi PB, Saultz JN, McCurdy SR, Morris L, Imus P, Hogan WJ, Nadiminti K, Bhatt VR, Olin R, Maakaron J, Sobecks R, Wall S, Mattila D, Protz B, Devine SM, Horowitz MM, Sorror ML. CHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study. Blood advances. 2026. PMID: 41269781

Gilligan T, Bohlke K, Alpert AB, Coyle N, Harichand-Herdt S, Lathan CS, Razis E, Rivera K, Sanft T, Seigel C, Times M, Chou CL. Patient-Clinician Communication: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2026. PMID: 41805420

Graham AJ, Khoo MWL, Srivastava V, Viragova S, Kim H, Parekh K, Hennick KM, Bird M, Goldhammer N, Yu JZ, Hu G, Brinkley NT, Pardo L, Amaya JS, Morley CD, Chadha N, Lebel P, Kumar S, Rosenbluth JM, Nowakowski TJ, Chaudhuri O, Klein O, Gómez-Sjöberg R, Gartner ZJ. Stress-relaxing granular bioprinting materials enable complex and uniform organoid self-organization. Nature materials. 2026. PMID: 41807773

Jacob S, Mayer EL, Kacik N, Storniolo AM, Isaacs C, Mayer I, Stearns V, Nanda R, Nangia J, Chien AJ, Moasser M, Melisko M, Wabl C, Muzikansky A, Geradts J, Dillon DA, Park BH, Krop I, Wolff AC, Kochupurakkal B, Shapiro GI, Rugo HS. TBCRC 035: randomized phase II pharmacodynamic study of standard and reduced-dose palbociclib with endocrine therapy in hormone receptor (HR)-positive previously treated metastatic breast cancer. ESMO open. 2026. PMID: 41812623

Neyazi N, Chakravarty D, Xia F, Hawes MR, Max W, Kushel M, Vijayaraghavan M. Attitudes toward tobacco-free and cannabis-free policies among residents in permanent supportive housing who use tobacco, cannabis, and other substances. Addictive behaviors reports. 2026. PMID: 41858814

Datta D, Nzau M. Targeted therapy for ALK-positive histiocytosis masquerading as optic nerve tumor: a case report. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery. 2026. PMID: 41803275

Vijayaraghavan M, Williams A, Bonniot C, Cheng C, Clark B, Safier J, Satterfield J, Pamatmat M, Schroeder SA. State Leadership Academies to Reduce Tobacco Use Prevalence in the United States: Four Case Studies of Early State Adopters of Tobacco Treatment and Policy. Public health reports (Washington, D.C. : 1974). 2026. PMID: 41797633

Al-Toma D, Kemna R, Ali M, Zwart K, Zeeuw MJ, Stehouwer BL, de Jong PA, Kurk S, Braat MNGJA, Lagendijk JJW, May AM, Koopman M, Verpalen IM, Swijnenburg RJ, Punt CJA, Kazemier G, Bol GM. Tumor burden in metastatic colorectal cancer quantified using deep learning models: Prognostic value and maintenance treatment benefit in the CAIRO3 trial. European journal of cancer (Oxford, England : 1990). 2026. PMID: 41819026

Nadine Goldhammer, Marin Bont, Shruti Warhadpande, Michael Choi, Jose Cedano, Heather Greenwood, Julia Ye, Christopher Schwartz, Michael Alvarado, Cheryl Ewing, Karen Goodwin, Rita Mukhtar, Jasmine Wong, Shoko Abe, Julia Chandler, Jordan Jackson, Olufunmilayo Olopade, Michael Campbell, Allison Lam, Chaelee Park, Anna Vertido, Laura van 't Veer, Nola Hylton, Laura Esserman, Jennifer Rosenbluth. Hormone signaling and immune programs define differential endocrine responsiveness in high-risk breast tissue bioRxiv. 2026. PMID:

Corona M, García-Vicente R, Saez-Marin AJ, Ancos-Pintado R, Rodríguez-Garcia A, Arroyo A, Blanco A, Chari A, Martin T, Wolf J, Rey-Bua B, Mateos MV, Kortüm KM, Riedhammer C, Tamariz-Amador LE, Valencia E, Rodríguez-Otero P, San Miguel J, Ibarra G, Oriol A, Cedena MT, López-Muñoz N, Alonso R, Calbacho M, Sanchez-Pina JM, Linares M, Martínez-López J. Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myeloma. Journal for immunotherapy of cancer. 2026. PMID: 41791791

Kim J, Munster PN. Cracks in the Estrogen Carcinogenesis of Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2026. PMID: 41785447

Jhaveri K, Bidard FC, Kalinsky K, Neven P, Rugo HS, Tolaney SM, Litchfield LM, von Laue CC, Traore S, Sapunar F, Li Y, O'Shaughnessy J. Imlunestrant plus abemaciclib versus fulvestrant plus abemaciclib in ER-positive, HER2-negative advanced breast cancer: an indirect treatment comparison of three phase III trials. ESMO open. 2026. PMID: 41785668

Bivona TG, Yanai I, Calabrò F, Mechta-Grigoriou F, Corleone G, Di Martile M, Tocci A, Tocci P, Vaccarella S, Ferriero MC, Alimonti A, Ruppin E, Nisticò P, Bagnato A, Blandino G. Challenges and advances in drug resistance and tolerance in cancer. Journal of experimental & clinical cancer research : CR. 2026. PMID: 41776655

Slovin S, Gao X, Wei XX, Oh DY, McKay RR, Falchook G, Hussain A, McKean M, Wibmer A, Ho A, Eskew JD, Belani R, Coronella J, Haag S, Martin CE, McCaigue J, Mendoza J, Murphy A, Namini H, Spear MA, Shedlock DJ, Dorff TB. Phase 1 Trial of P-PSMA-101 CAR-T Cells in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC). Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 41779004

Goldhammer N, Bont M, Warhadpande S, Choi M, Cedano J, Greenwood H, Ye J, Schwartz CJ, Alvarado M, Ewing C, Goodwin K, Mukhtar RA, Wong J, Abe SE, Chandler J, Jackson J, Olopade OI, Campbell MJ, Lam A, Park C, Vertido A, van 't Veer LJ, Hylton N, Esserman LJ, Rosenbluth JM. Hormone signaling and immune programs define differential endocrine responsiveness in high-risk breast tissue. bioRxiv : the preprint server for biology. 2026. PMID: 41867809